SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCONI, Peggy Carla Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.028
AS - Asia 6.270
EU - Europa 3.633
SA - Sud America 998
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 141
OC - Oceania 14
Totale 24.320
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.699
SG - Singapore 2.297
CN - Cina 1.491
IT - Italia 876
BR - Brasile 750
VN - Vietnam 668
UA - Ucraina 543
HK - Hong Kong 531
GB - Regno Unito 465
DE - Germania 421
PL - Polonia 351
TR - Turchia 343
BD - Bangladesh 277
FR - Francia 224
FI - Finlandia 193
JP - Giappone 185
CA - Canada 153
RU - Federazione Russa 147
IN - India 115
SE - Svezia 112
MX - Messico 102
AR - Argentina 92
ID - Indonesia 90
NL - Olanda 79
ZA - Sudafrica 61
ES - Italia 49
IQ - Iraq 46
CO - Colombia 43
PK - Pakistan 42
EC - Ecuador 33
BE - Belgio 30
AT - Austria 28
UZ - Uzbekistan 27
VE - Venezuela 24
LT - Lituania 22
MY - Malesia 22
CL - Cile 20
JM - Giamaica 20
SA - Arabia Saudita 19
MA - Marocco 18
PH - Filippine 17
PY - Paraguay 17
IE - Irlanda 16
AE - Emirati Arabi Uniti 15
AU - Australia 14
CZ - Repubblica Ceca 14
CR - Costa Rica 13
CH - Svizzera 12
NP - Nepal 12
UY - Uruguay 10
ET - Etiopia 9
PA - Panama 9
PT - Portogallo 9
AL - Albania 8
HN - Honduras 8
KE - Kenya 8
AZ - Azerbaigian 7
DZ - Algeria 7
EG - Egitto 7
IL - Israele 7
IR - Iran 7
TN - Tunisia 7
JO - Giordania 6
BO - Bolivia 5
GE - Georgia 5
KR - Corea 5
MD - Moldavia 5
NO - Norvegia 5
OM - Oman 5
TH - Thailandia 5
BB - Barbados 4
GT - Guatemala 4
LB - Libano 4
RO - Romania 4
CG - Congo 3
KW - Kuwait 3
KZ - Kazakistan 3
MZ - Mozambico 3
NI - Nicaragua 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
BY - Bielorussia 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
MM - Myanmar 2
MN - Mongolia 2
NG - Nigeria 2
PR - Porto Rico 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
Totale 24.061
Salva come PNG Salva come JPEG
Città #
Ashburn 1.574
Singapore 1.500
Fairfield 1.049
Woodbridge 1.035
San Jose 968
Houston 616
Jacksonville 560
Santa Clara 540
Hong Kong 519
Chandler 498
Beijing 482
Ann Arbor 437
Council Bluffs 437
Seattle 420
New York 379
Wilmington 363
Cambridge 338
Warsaw 338
Ferrara 224
Ho Chi Minh City 212
Dallas 211
Los Angeles 211
Izmir 188
Tokyo 172
Hanoi 166
Nanjing 149
Princeton 135
Lauterbourg 133
San Diego 108
Munich 104
Milan 101
São Paulo 88
Buffalo 69
Shanghai 67
Mexico City 61
Jakarta 59
Bologna 56
Chicago 55
Tianjin 55
Boardman 54
Orem 53
Shenyang 53
Montreal 50
Brooklyn 47
Toronto 46
Helsinki 43
London 43
Rome 43
The Dalles 43
Turku 39
Hebei 37
Hefei 37
Poplar 35
Chennai 34
Jiaxing 34
Atlanta 33
Da Nang 33
Nanchang 32
Phoenix 32
Frankfurt am Main 31
Johannesburg 31
San Francisco 31
Brussels 29
Stockholm 29
Changsha 28
Moscow 27
Boston 25
Manchester 25
Washington 25
Denver 23
Falls Church 22
Haiphong 22
Tashkent 22
Naples 21
Guangzhou 19
Norwalk 19
Rio de Janeiro 19
Vienna 19
Amsterdam 18
Falkenstein 18
Mountain View 18
Baghdad 17
Brasília 16
Dublin 16
Ningbo 16
Redwood City 16
New Delhi 15
San Mateo 15
Ankara 14
Bogotá 14
Dong Ket 14
Jinan 14
Kingston 14
Kunming 14
Lahore 14
Nuremberg 14
Zhengzhou 14
Auburn Hills 13
Medellín 13
Newark 13
Totale 16.295
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 338
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 284
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 278
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis 278
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 275
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 273
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 264
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 252
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 250
Recombinant herpes simplex virus and uses therefor 240
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 239
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 236
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 234
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 227
HSV as a vector in vaccine development and gene therapy 221
Sustainable vs. Conventional Cleaning in Healthcare: Microbiological and Life Cycle Insights 221
Botulinum neurotoxin light chains expressed by defective herpes simplex virus type-1 vectors cleave snare proteins and inhibit cgrp release in rat sensory neurons 219
Capitolo 55 Retrovirus 213
Herpesvirus-based vaccines 213
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 211
Generation of a human induced pluripotent stem cell line (UNIFEi001-A) from a patient with Spinocerebellar ataxia type 1 (SCA1) 207
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 206
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 204
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 203
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 201
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 200
Development and application of replication-incompetent HSV-1-based vectors 199
Herpes Simplex Virus Growth, Preparation, and Assay 199
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 199
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 198
HSV as a vector in vaccine development and gene therapy 197
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma 194
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 194
Temporal lobe epilepsy model, neural stem cells and gene therapy 193
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 191
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 190
Herpes simplex virus type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment 189
Purinergic Signaling: A New Pharmacological Target Against Viruses? 189
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 187
Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment 187
Engineering herpes simplex virus vectors for CNS applications 185
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 185
Herpetic vectors inhibiting angiogenesis and Inducing cell suicide in gliomas 183
Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections 182
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8(+) T cell tolerance in vivo 180
null 179
Gene transfer to muscle using herpes simplex virus-based vectors 177
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 177
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 176
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 176
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy 174
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 174
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 172
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications 171
Parenchymal cells critically curtail cytotoxic T-cell responses by inducing Bim-mediated apoptosis 170
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 170
An Evaluation of Hospital Cleaning Regimes—Microbiological Evaluation and LCA Analysis after Traditional and Sustainable/Green Procedures 169
Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis 168
Herpes Simplex Virus Type 1-Derived Recombinant and Amplicon Vectors 168
Herpes Simplex Virus ICP27 Protein Inhibits AIM 2-Dependent Inflammasome Influencing Pro-Inflammatory Cytokines Release in Human Pigment Epithelial Cells (hTert-RPE 1) 167
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity 167
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis 167
Capitolo 44 Herpesviridae 167
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system 166
Construction of Replication Defective Herpes Simplex Virus Vectors. 166
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 165
Development of Replication-Defective Herpes Simplex Virus Vectors 165
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 165
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines 164
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 164
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 163
Peripheral T Cells Re-Enter the Thymus and Interfere with Central Tolerance Induction 163
Analysis of Civil Environments Cleaning Services—Microbiological and LCA Analysis after Traditional and Sustainable Procedures 162
MHC class I cross-presentation by dendritic cells counteracts viral immune evasion 162
Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors 161
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo 160
Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target 158
Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance 158
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 157
A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties 156
HSV Recombinant Vectors for Gene Therapy 156
Connexin 43-enhanced suicide gene therapy using herpesviral vectors 155
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 154
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model 153
Evaluating Cleaning Services in Civil Environments: Microbiological and Life Cycle Analysis Comparing Conventional and Sustainable Methods 151
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 151
Natural Polyphenol-Containing Gels against HSV-1 Infection: A Comparative Study 151
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 149
Comunicazione orale, Keynote speaker: Herpes Simplex Vector Expressing Hiv1 Tat: A New Strategy For Vaccine Development 149
Mangiferin loaded smart gels for HSV-1 treatment 149
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons 148
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice 145
Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis 142
Rapid method for construction of recombinant HSV gene transfer vectors 142
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector 141
Replication-defective herpes simplex virus vectors for gene transfer in vivo 140
Chapter 8: Gene-transfer Tool: Herpes Simplex Virus Vectors 140
A multi-technique approach to enlighten the role of metal coordination in calcitermin antiviral properties 139
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 139
Implications of maturation for viral gene delivery to skeletal muscle 138
Totale 18.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 16.800
Totale 128.052
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.153 0 0 75 63 53 48 94 80 61 103 134 442
2022/20231.200 147 29 63 136 159 181 47 140 172 21 73 32
2023/2024890 80 85 42 26 39 264 55 43 21 25 22 188
2024/20252.886 82 80 235 112 385 317 47 172 380 332 426 318
2025/20269.586 962 347 817 1.178 1.262 623 1.024 514 979 1.030 579 271
2026/20271.176 371 560 245 0 0 0 0 0 0 0 0 0
Totale 24.320